{"id":"https://openalex.org/W1997146937","doi":"https://doi.org/10.1159/000320686","title":"High Plasma TIMP-1 and Serum CEA Levels during Combination Chemotherapy for Metastatic Colorectal Cancer Are Significantly Associated with Poor Outcome","display_name":"High Plasma TIMP-1 and Serum CEA Levels during Combination Chemotherapy for Metastatic Colorectal Cancer Are Significantly Associated with Poor Outcome","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W1997146937","doi":"https://doi.org/10.1159/000320686","mag":"1997146937","pmid":"https://pubmed.ncbi.nlm.nih.gov/21150229"},"language":"en","primary_location":{"id":"doi:10.1159/000320686","doi":"https://doi.org/10.1159/000320686","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000320686","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007555589","display_name":"Bahir Hadi Aldulaymi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Bahir Aldulaymi","raw_affiliation_strings":["Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden. bahirhadi@hotmail.com","Department of Surgery, Hiller\u00f8d Hospital, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden. bahirhadi@hotmail.com","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Department of Surgery, Hiller\u00f8d Hospital, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113614070","display_name":"Per Bystr\u00f6m","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Per Bystr\u00f6m","raw_affiliation_strings":["Department of Oncology and Pathology, Karolinska Institutet, Stockholm, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Pathology, Karolinska Institutet, Stockholm, and","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013720146","display_name":"\u00c5ke Berglund","orcid":"https://orcid.org/0000-0002-5240-3106","observed_orcids":["https://orcid.org/0000-0002-5240-3106"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"\u00c5ke Berglund","raw_affiliation_strings":["Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063977962","display_name":"Ib Jarle Christensen","orcid":"https://orcid.org/0000-0002-3017-7195","observed_orcids":["https://orcid.org/0000-0002-3017-7195"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ib J. Christensen","raw_affiliation_strings":["Finsen Laboratory, National Hospital, Hiller\u00f8d,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finsen Laboratory, National Hospital, Hiller\u00f8d,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112322618","display_name":"Nils Br\u00fcnner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Nils Br\u00fcnner","raw_affiliation_strings":["Institute of Veterinary Disease Biology, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Veterinary Disease Biology, Faculty of Life Sciences, University of Copenhagen, Frederiksberg, and","institution_ids":["https://openalex.org/I124055696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083521662","display_name":"Hans J\u00f8rgen Nielsen","orcid":"https://orcid.org/0000-0003-2619-4379","observed_orcids":["https://orcid.org/0000-0003-2619-4379"]},"institutions":[{"id":"https://openalex.org/I2801942218","display_name":"Hvidovre Hospital","ror":"https://ror.org/00edrn755","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801942218","https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Hans J. Nielsen","raw_affiliation_strings":["Department of Surgical Gastroenterology, Hvidovre Hospital, Hvidovre, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Gastroenterology, Hvidovre Hospital, Hvidovre, Denmark","institution_ids":["https://openalex.org/I2801942218"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057158252","display_name":"Bengt L. G. Glimelius","orcid":"https://orcid.org/0000-0002-5440-791X","observed_orcids":["https://orcid.org/0000-0002-5440-791X"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Bengt Glimelius","raw_affiliation_strings":["Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8119,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.73391336,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"79","issue":"1-2","first_page":"144","last_page":"149"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9639999866485596},{"id":"https://openalex.org/keywords/timp-1","display_name":"TIMP-1","score":0.8790000081062317},{"id":"https://openalex.org/keywords/carcinoembryonic-antigen","display_name":"carcinoembryonic antigen","score":0.9010000228881836},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.7519999742507935},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9940000176429749},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.9879999756813049},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8870000243186951},{"id":"https://openalex.org/keywords/objective-response","display_name":"objective response","score":0.824999988079071},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.9980000257492065},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7940000295639038}],"concepts":[{"id":"https://openalex.org/C2777387746","wikidata":"https://www.wikidata.org/wiki/Q769706","display_name":"Carcinoembryonic antigen","level":3,"score":0.8646966218948364},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.854932427406311},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7362478375434875},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7291567921638489},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.6904402375221252},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6327066421508789},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5750059485435486},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.4358454942703247},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.42780542373657227},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3546622395515442}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002272","descriptor_name":"Carcinoembryonic Antigen","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013548","descriptor_name":"Sweden","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D015337","descriptor_name":"Multicenter Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019715","descriptor_name":"Tissue Inhibitor of Metalloproteinase-1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1159/000320686","doi":"https://doi.org/10.1159/000320686","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000320686","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},{"id":"pmid:21150229","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21150229","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/f6dfcf77-6052-4823-b5e7-0fe94c3e39c7","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/f6dfcf77-6052-4823-b5e7-0fe94c3e39c7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Aldulaymi, B, Bystr\u00f6m, P, Berglund, A, Christensen, I J, Br\u00fcnner, N, Nielsen, H J & Glimelius, B 2010, 'High Plasma TIMP-1 and Serum CEA Levels during Combination Chemotherapy for Metastatic Colorectal Cancer Are Significantly Associated with Poor Outcome', Oncology, vol. 79, no. 1-2, pp. 144-149. https://doi.org/10.1159/000320686","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W317545","https://openalex.org/W1691844459","https://openalex.org/W1859093747","https://openalex.org/W1965734230","https://openalex.org/W1965876379","https://openalex.org/W1978939787","https://openalex.org/W1987065859","https://openalex.org/W1991803238","https://openalex.org/W2004726560","https://openalex.org/W2020270739","https://openalex.org/W2058681003","https://openalex.org/W2072617189","https://openalex.org/W2080071965","https://openalex.org/W2080850469","https://openalex.org/W2094193884","https://openalex.org/W2096447236","https://openalex.org/W2099052946","https://openalex.org/W2111378907","https://openalex.org/W2116781863","https://openalex.org/W2119050264","https://openalex.org/W2121061548","https://openalex.org/W2127670800","https://openalex.org/W2128601920","https://openalex.org/W2139248078","https://openalex.org/W2148573825","https://openalex.org/W2148847930","https://openalex.org/W2155311724","https://openalex.org/W2164194457","https://openalex.org/W2186210876","https://openalex.org/W2288400816","https://openalex.org/W2337400443","https://openalex.org/W2409306424"],"related_works":["https://openalex.org/W1987065859","https://openalex.org/W2139017525","https://openalex.org/W2873990260","https://openalex.org/W2111378907","https://openalex.org/W2158346116","https://openalex.org/W2337400443","https://openalex.org/W2590732882","https://openalex.org/W2602152301","https://openalex.org/W1484086538","https://openalex.org/W2109078669"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"whether":[3,27],"combination":[4],"chemotherapy":[5,225],"leads":[6],"to":[7,31,36,129],"early":[8],"changes":[9,29],"in":[10,19,188,234,244],"plasma":[11,95,111,137,172,209,232],"TIMP-1":[12,71,96,112,138,173,210,233],"and":[13,26,39,57,61,72,97,113,120,125,141,145,175,198,236],"serum":[14,73,98,115,157,196,212,237],"carcinoembryonic":[15],"antigen":[16],"(CEA)":[17],"levels":[18,75,100,117,135,155,170,214],"patients":[20,46],"with":[21,47,66,150,165,181,249],"metastatic":[22],"colorectal":[23],"cancer":[24],"(mCRC),":[25],"such":[28],"relate":[30],"subsequent":[32],"objective":[33,131],"response,":[34],"time":[35],"progression":[37],"(TTP)":[38],"overall":[40,183,199],"survival.":[41],"MATERIALS":[42],"AND":[43],"METHODS:":[44],"Eighty-eight":[45],"mCRC":[48],"were":[49,53,76,127,147,162,178],"included.":[50],"Blood":[51],"samples":[52,245],"collected":[54,246],"before":[55,118,139,174,205],"initiation":[56],"after":[58,88],"2,":[59,123],"4":[60,124,146,161,190],"6":[62,106,126,222],"weeks":[63,90,107,122,143,223],"of":[64,91,108,136,156,171,224],"treatment":[65,119,140,177,248],"an":[67],"irinotecan-5-fluorouracil":[68],"combination.":[69],"Plasma":[70],"CEA":[74,99,116,158,197,213,238],"determined":[77],"by":[78],"validated":[79],"ELISA":[80],"platforms.":[81],"The":[82,228],"first":[83,221],"response":[84],"evaluation":[85],"was":[86],"performed":[87],"8":[89],"chemotherapy.":[92,250],"RESULTS:":[93],"Median":[94,208],"did":[101],"not":[102,216],"change":[103,217],"significantly":[104,148,163,179,218],"during":[105,176,219,247],"treatment.":[109,206],"High":[110],"high":[114,134,154,169],"at":[121,142,159],"related":[128],"poor":[130,182],"response.":[132],"Moreover,":[133],"2":[144],"associated":[149,164,180],"short":[151,166],"TTP,":[152],"while":[153],"week":[160],"TTP.":[167],"Finally,":[168],"survival;":[184],"p":[185],"<":[186],"0.0001":[187],"all":[189],"determinations.":[191],"A":[192],"similar":[193],"association":[194],"between":[195],"survival":[200],"could":[201],"only":[202],"be":[203,240],"demonstrated":[204],"CONCLUSION:":[207],"or":[211],"do":[215],"the":[220],"for":[226],"mCRC.":[227],"results":[229],"indicate":[230],"that":[231],"particular":[235],"may":[239],"valuable":[241],"biomarkers":[242],"even":[243]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}